ATE366810T1 - Menschliche p51-gene und deren genprodukte - Google Patents

Menschliche p51-gene und deren genprodukte

Info

Publication number
ATE366810T1
ATE366810T1 AT99910698T AT99910698T ATE366810T1 AT E366810 T1 ATE366810 T1 AT E366810T1 AT 99910698 T AT99910698 T AT 99910698T AT 99910698 T AT99910698 T AT 99910698T AT E366810 T1 ATE366810 T1 AT E366810T1
Authority
AT
Austria
Prior art keywords
genes
human
gene products
protein
recombinant
Prior art date
Application number
AT99910698T
Other languages
English (en)
Inventor
Yoji Ikawa
Shuntaro Ikawa
Masuo Obinata
Original Assignee
Otsuka Pharma Co Ltd
Yoji Ikawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd, Yoji Ikawa filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE366810T1 publication Critical patent/ATE366810T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747Apoptosis related proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT99910698T 1998-03-27 1999-03-24 Menschliche p51-gene und deren genprodukte ATE366810T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10046798 1998-03-27

Publications (1)

Publication Number Publication Date
ATE366810T1 true ATE366810T1 (de) 2007-08-15

Family

ID=14274724

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07013470T ATE512162T1 (de) 1998-03-27 1999-03-24 Antikörper gegen das p51 protein
AT99910698T ATE366810T1 (de) 1998-03-27 1999-03-24 Menschliche p51-gene und deren genprodukte

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT07013470T ATE512162T1 (de) 1998-03-27 1999-03-24 Antikörper gegen das p51 protein

Country Status (12)

Country Link
US (4) US7132276B1 (de)
EP (2) EP1847607B1 (de)
JP (1) JP4336926B2 (de)
CN (1) CN100340665C (de)
AT (2) ATE512162T1 (de)
CA (1) CA2324649C (de)
CY (1) CY1111763T1 (de)
DE (1) DE69936513D1 (de)
DK (1) DK1847607T3 (de)
ES (1) ES2366234T3 (de)
PT (1) PT1847607E (de)
WO (1) WO1999050412A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2377438A1 (en) 1999-06-29 2001-01-04 Nippon Kayaku Kabushiki Kaisha Gene encoding promoter domain of tumor suppressor gene p51 and use thereof
TW200532523A (en) * 2004-02-27 2005-10-01 Aureon Biosciences Corp Methods and systems for predicting occurrence of an event
CN102181571A (zh) * 2011-05-20 2011-09-14 清华大学 辅助鉴定猪遗传稳定性相关基因的专用引物及其应用
CN102181570A (zh) * 2011-05-20 2011-09-14 清华大学 辅助鉴定鼠遗传稳定性相关基因的专用引物及其应用
CN104212879B (zh) * 2013-06-05 2016-09-21 上海派森诺生物科技股份有限公司 一种基于磁珠富集法高通量开发基因组ssr标记的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744455B1 (fr) 1996-02-02 1998-04-24 Sanofi Sa Nouvelles sequences d'acides nucleiques de la famille des facteurs suppresseurs de tumeurs, produits d'expression correspondants et leurs applications
AU7478098A (en) 1997-05-12 1998-12-08 Dana-Farber Cancer Institute Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
US7294459B1 (en) * 1997-10-15 2007-11-13 President And Fellows Of Harvard College Cell regulatory genes, encoded products, and uses related thereto
WO1999019357A2 (en) * 1997-10-15 1999-04-22 President And Fellows Of Harvard College Cell regulatory genes, encoded products, and uses related thereto
WO1999047674A2 (en) 1998-03-18 1999-09-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
WO1999050287A2 (en) 1998-03-27 1999-10-07 The Johns Hopkins University P40 protein acts as an oncogene
DE19822985C1 (de) 1998-05-25 2000-01-13 Fraunhofer Ges Forschung Tumorsuppressorgene der p53-Familie

Also Published As

Publication number Publication date
JP4336926B2 (ja) 2009-09-30
DE69936513D1 (de) 2007-08-23
CY1111763T1 (el) 2015-10-07
HK1034288A1 (en) 2001-10-19
US7553933B2 (en) 2009-06-30
EP1847607A1 (de) 2007-10-24
EP1847607B1 (de) 2011-06-08
WO1999050412A1 (en) 1999-10-07
CN100340665C (zh) 2007-10-03
CA2324649C (en) 2007-05-15
EP1065270B1 (de) 2007-07-11
US20090142783A1 (en) 2009-06-04
PT1847607E (pt) 2011-08-25
US7132276B1 (en) 2006-11-07
EP1065270A4 (de) 2004-12-29
EP1065270A1 (de) 2001-01-03
CA2324649A1 (en) 1999-10-07
US20100285499A1 (en) 2010-11-11
ES2366234T3 (es) 2011-10-18
ATE512162T1 (de) 2011-06-15
DK1847607T3 (da) 2011-07-18
US7964367B2 (en) 2011-06-21
US7754857B2 (en) 2010-07-13
CN1295615A (zh) 2001-05-16
US20060115852A1 (en) 2006-06-01

Similar Documents

Publication Publication Date Title
ATE295414T1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
DE69535147D1 (de) Überexpression von säugetier- und virusproteinen
ATE382055T1 (de) Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren
ATE339878T1 (de) Myc-bindende zinkfinger-proteine, ihre herstellung und ihre verwendung
DK1025236T3 (da) Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
ATE534742T1 (de) Polypeptide und nukleinsäuren von phorphorymonas gingivalis
CY1111763T1 (el) ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51
WO2000040723A3 (en) Methods and products for delivering nucleic acids
NO980122L (no) Emaljematriksrelatert polypeptid
AU1444699A (en) Single-chain polypeptides comprising troponin i and troponin
NO874704L (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
DE60142356D1 (de) 18480 humane proteinkinasemoleküle und ihre verwendungen
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
EP0723014A3 (de) cDNA des DOCK180 Gens und DOCK180 Protein
EP0723016A3 (de) Leukocyten-aktivierender Faktor
WO2002012475A3 (en) C1q-related factor, homologous polypeptides and therapeutic uses thereof
WO2003018806A1 (fr) Nouveau gene humain bmcc1
DE69932644D1 (de) Menschliches Protein mit in vitro antiproliferativer Aktivität.
WO2003099995A3 (en) Murine ortholog of the human disrupted-in-schizophrenia 1 gene
CO5070672A1 (es) Polipeptido de proteina c humana
AU7871101A (en) Nucleic acids and proteins showing increased expression dose under salt stress
WO2003008621A3 (en) 87144, human amino acid transporter family member and uses therefor
WO2002024913A3 (en) 32612, a novel human peptide transporter and uses therefor
WO2000063370A3 (en) Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties